🔴 Cerenome is trading 8% down in pre-market

Cerenome is trading at $1.57, down -7.65% in pre-market, with no clear company-specific catalyst identified.

• No new company-specific announcement explaining the November 2 decline surfaced in the available search.
• The October 29 trial-enrollment announcement is prior news, not a clear catalyst for this drop; broader indices are higher, so the decline is moving against the market trend.
• Pre-market volume was not provided, so trading activity cannot be assessed.